The aim of the study is to determine if single fraction dose escalated palliative radiotherapy results in a prolonged duration of benefit for patients otherwise suitable for Multifraction (5-10#) palliative radiation. The primary endpointis to determine the percentage of patients who have achieved a substantial benefit from palliative radiotherapy and have not redeveloped symptoms by 12 months post treatment
Metastatic cancer
Recommended for 5-10 fractions palliative radiation
Patients with spinal cord compression are eligible for enrolment
Unwilling or unable to give informed consent
Patients who are recommended for single fraction palliative radiation
Map coordinates are unavailable for these locations. Locations are shown below instead.
AustraliaRoyal North Shore Hospital
Lead sponsor
Northern Sydney and Central Coast Area Health Service
Collaborator